Home › Colorectal Cancer › Minnesota › Minneapolis
Pag-aaral pangklinika para sa Colorectal Cancer sa Minneapolis, MN
19 pag-aaral para sa Colorectal Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Minneapolis (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
The Vanguard Study: Testing a New Way to Screen for Cancer
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Minneapolis VA Medical Center, Minneapolis
Family Communications After Genetic Testing
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi ang layo
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi ang layo
PRE-ISPY Phase I/II Oncology Platform Program
Nagre-recruitPhase 1/2
- University of Minnesota Masonic Cancer Center, Minneapolis
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Nagre-recruitPhase 3
- University of Minnesota/Masonic Cancer Center, Minneapolis
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Nagre-recruitPhase 1/2
- Masonic Cancer Center University of Minnesota, Minneapolis
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
Nagre-recruitPhase 3
- Minnesota Oncology Hematology, P.A., Saint Louis Park · 5 mi ang layo
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Nagre-recruitPhase 3
- Clinical Study Site, Saint Louis Park · 5 mi ang layo
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
- University of Minnesota Masonic Cancer Center, Minneapolis
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Nagre-recruitPhase 1/2
- University of Minnesota/Masonic Cancer Center, Minneapolis
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- M Health Fairview University of Minnesota Medical Center, Minneapolis
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Nagre-recruitPhase 1/2
- M Health Fairview University of Minnesota Medical Center, Minneapolis
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Nagre-recruitPhase 3
- Allina Health Cancer Institute (Virginia Piper Cancer Institute), Minneapolis
- Minnesota Oncology Hematology, PA, Minneapolis
- Hennepin County Medical Center, Minneapolis
- at 3 pa
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Nagre-recruitPhase 2
- Scri Minnesota Oncology Hematology, P.A. /ID# 275149, Minneapolis
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi ang layo
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Nagre-recruitObservasyonal na pag-aaral
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi ang layo
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Allina Health Cancer Institute, Minneapolis
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Nagre-recruitObservasyonal na pag-aaral
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi ang layo
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Nagre-recruitObservasyonal na pag-aaral
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi ang layo
Pag-aaral para sa Colorectal Cancer sa ibang lungsod
- Houston, TX102 pag-aaral
- New York City, NY78 pag-aaral
- Nashville, TN69 pag-aaral
- Boston, MA63 pag-aaral
- Los Angeles, CA59 pag-aaral
- Arlington, VA52 pag-aaral
- St. Louis, MO50 pag-aaral
- San Antonio, TX46 pag-aaral
- Philadelphia, PA44 pag-aaral
- Grand Rapids, MI40 pag-aaral
- Baldwin Park, CA37 pag-aaral
- Chicago, IL34 pag-aaral
Iba pang pag-aaral sa Minneapolis
- Non-Small Cell Lung Cancer27 pag-aaral
- Kanser sa Suso27 pag-aaral
- Kanser sa Ovary24 pag-aaral
- Kanser sa Prostate23 pag-aaral
- Kanser (lahat ng uri)22 pag-aaral
- Pagkabigo ng Puso21 pag-aaral
- Acute Myeloid Leukemia20 pag-aaral
- Kanser sa Baga20 pag-aaral
- Kanser ng Endometrium18 pag-aaral
- Sakit ni Parkinson17 pag-aaral
- Sakit sa Puso at Ugat ng Dugo15 pag-aaral
- Sakit sa Coronary Artery13 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.